BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2024 8:41:19 AM | Browse: 277 | Download: 1125
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 98243
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Prognostic value of PEA3 subfamily gene expression in cholangiocarcinoma
Manuscript Source Unsolicited Manuscript
All Author List Li Wang, Zhe Zhang and Hai-Zhang Ma
ORCID
Author(s) ORCID Number
Li Wang http://orcid.org/0000-0002-3356-0704
Zhe Zhang http://orcid.org/0009-0009-4009-2396
Funding Agency and Grant Number
Funding Agency Grant Number
Science and Technology Development Plan Project of Hangzhou No. 20201203B56
Corresponding Author Zhe Zhang, Doctor, Doctor, Doctor, Department of Emergency Medicine, The First People’s Hospital of Linping District Hangzhou, No. 369 Yingbin Road, Nanyuan Street, Linping District, Hangzhou 311100, Zhejiang Province, China. zz2516116@163.com
Key Words PEA3 subfamily; Cholangiocarcinoma; The cancer genome atlas; ETV4; The prognosis; Prognostic biomarker
Core Tip This study investigates the expression of the PEA3 subfamily genes (ETV1, ETV4, ETV5) in cholangiocarcinoma (CCA) and their clinical relevance. Using data from cancer genome atlas and genotype-tissue expression project databases, we identified significantly elevated levels of ETV1, ETV4 and ETV5 in CCA. High expression of ETV1 and ETV4 was explicitly correlated with shorter overall survival in CCA patients. Functional assays demonstrated that silencing PEA3 genes reduces invasion and metastasis in CCA cells in vitro and in vivo. These findings suggest that ETV4 may be a valuable prognostic biomarker for survival of CCA patients.
Publish Date 2024-09-09 08:41
Citation

Wang L, Zhang Z, Ma HZ. Prognostic value of PEA3 subfamily gene expression in cholangiocarcinoma. World J Gastrointest Oncol 2024; 16(9): 4014-4027

URL https://www.wjgnet.com/1948-5204/full/v16/i9/4014.htm
DOI https://dx.doi.org/10.4251/wjgo.v16.i9.4014
Full Article (PDF) WJGO-16-4014-with-cover.pdf